Stock listing
NASDAQ:BBLG Bone Biologics Corp Stock
Home listing (NASDAQ) of Bone Biologics Corp
Follow Bone Biologics Corp into a list and get an email when it puts out news.
Share price · NASDAQ:BBLG
$0.269 USD -0.022 (-7.7%)
Close on Nov 20, 2026
- Day range
- $0.268 – $0.285 USDNov 20, 2026
- Volume
- 36,490 sharesNov 20, 2026
- Market cap
- $909,962 USDAt the close on Nov 20, 2026 · price × 3.39M shares outstanding
- 52-week range
- $0.266 – $2.390 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $112,869 USDMedian day 38,557 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BBLG · Home | $0.269 USD | -0.022 (-7.7%) | 36,490 | $0.276 | $0.285 | $0.268 | $0.291 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:BBLG · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.269 | -0.022 | -7.7% | $0.276 | $0.285 | $0.268 | 36,490 | |
| $0.291 | -0.018 | -5.9% | $0.317 | $0.317 | $0.281 | 38,557 | |
| $0.309 | +0.015 | +5.1% | $0.311 | $0.323 | $0.282 | 39,735 | |
| $0.294 | -0.031 | -9.5% | $0.326 | $0.350 | $0.266 | 97,241 | |
| $0.325 | -0.075 | -18.7% | $0.375 | $0.392 | $0.325 | 297,701 | |
| $0.400 | +0.050 | +14.3% | $0.367 | $0.476 | $0.320 | 7,911,964 | |
| $0.350 | +0.009 | +2.6% | $0.343 | $0.375 | $0.340 | 15,604 | |
| $0.341 | +0.010 | +3.0% | $0.348 | $0.358 | $0.327 | 31,532 | |
| $0.331 | -0.002 | -0.6% | $0.334 | $0.390 | $0.322 | 54,521 | |
| $0.333 | +0.010 | +3.0% | $0.338 | $0.350 | $0.315 | 135,469 | |
| $0.324 | -0.023 | -6.7% | $0.348 | $0.348 | $0.322 | 40,397 | |
| $0.347 | -0.006 | -1.8% | $0.378 | $0.380 | $0.347 | 22,917 | |
| $0.354 | -0.017 | -4.7% | $0.367 | $0.371 | $0.352 | 36,655 | |
| $0.371 | -0.010 | -2.5% | $0.385 | $0.388 | $0.367 | 23,773 | |
| $0.380 | -0.008 | -2.0% | $0.403 | $0.403 | $0.376 | 14,407 | |
| $0.388 | -0.004 | -0.9% | $0.409 | $0.410 | $0.387 | 18,284 | |
| $0.392 | +0.024 | +6.5% | $0.407 | $0.420 | $0.389 | 46,671 | |
| $0.368 | -0.009 | -2.4% | $0.390 | $0.390 | $0.361 | 121,145 | |
| $0.377 | -0.018 | -4.6% | $0.390 | $0.407 | $0.370 | 25,825 | |
| $0.395 | -0.011 | -2.7% | $0.407 | $0.407 | $0.391 | 10,000 | |
| $0.406 | -0.014 | -3.3% | $0.410 | $0.417 | $0.392 | 25,100 | |
| $0.420 | -0.010 | -2.3% | $0.405 | $0.425 | $0.405 | 15,600 | |
| $0.430 | +0.019 | +4.6% | $0.425 | $0.443 | $0.411 | 14,500 | |
| $0.411 | +0.016 | +4.1% | $0.430 | $0.443 | $0.390 | 19,100 | |
| $0.395 | +0.007 | +1.8% | $0.405 | $0.409 | $0.385 | 59,700 | |
| $0.388 | -0.027 | -6.5% | $0.397 | $0.404 | $0.379 | 119,300 | |
| $0.415 | -0.015 | -3.5% | $0.418 | $0.418 | $0.391 | 58,100 | |
| $0.430 | -0.025 | -5.5% | $0.442 | $0.460 | $0.400 | 59,600 | |
| $0.455 | -0.012 | -2.6% | $0.466 | $0.466 | $0.440 | 33,700 | |
| $0.467 | -0.002 | -0.4% | $0.471 | $0.492 | $0.458 | 36,300 | |
| $0.469 | -0.019 | -3.9% | $0.475 | $0.475 | $0.468 | 9,700 | |
| $0.488 | +0.008 | +1.7% | $0.462 | $0.488 | $0.462 | 17,500 | |
| $0.480 | -0.005 | -1.0% | $0.496 | $0.496 | $0.462 | 53,700 | |
| $0.485 | +0.010 | +2.1% | $0.474 | $0.495 | $0.460 | 26,200 | |
| $0.475 | 0.000 | 0.0% | $0.479 | $0.481 | $0.466 | 20,600 | |
| $0.475 | -0.021 | -4.2% | $0.470 | $0.481 | $0.466 | 23,500 | |
| $0.496 | 0.000 | 0.0% | $0.491 | $0.496 | $0.475 | 36,700 | |
| $0.496 | 0.000 | 0.0% | $0.486 | $0.496 | $0.479 | 15,900 | |
| $0.496 | 0.000 | 0.0% | $0.480 | $0.496 | $0.480 | 33,400 | |
| $0.496 | +0.005 | +1.0% | $0.488 | $0.496 | $0.470 | 57,600 | |
| $0.491 | -0.015 | -3.0% | $0.529 | $0.550 | $0.476 | 229,200 | |
| $0.506 | +0.021 | +4.3% | $0.470 | $0.550 | $0.460 | 448,700 | |
| $0.485 | +0.009 | +1.9% | $0.495 | $0.499 | $0.466 | 53,200 | |
| $0.476 | -0.043 | -8.3% | $0.508 | $0.519 | $0.467 | 65,700 | |
| $0.519 | +0.019 | +3.8% | $0.520 | $0.525 | $0.500 | 119,900 | |
| $0.500 | -0.038 | -7.1% | $0.469 | $0.539 | $0.428 | 465,200 | |
| $0.538 | -0.002 | -0.4% | $0.531 | $0.550 | $0.531 | 4,176,500 | |
| $0.540 | 0.000 | 0.0% | $0.532 | $0.580 | $0.510 | 103,800 | |
| $0.540 | -0.011 | -2.0% | $0.540 | $0.568 | $0.540 | 24,300 | |
| $0.551 | -0.010 | -1.8% | $0.561 | $0.565 | $0.550 | 11,300 | |
| $0.561 | +0.007 | +1.3% | $0.562 | $0.575 | $0.551 | 17,500 | |
| $0.554 | -0.006 | -1.1% | $0.590 | $0.590 | $0.550 | 54,900 | |
| $0.560 | -0.008 | -1.4% | $0.582 | $0.585 | $0.560 | 14,800 | |
| $0.568 | +0.010 | +1.8% | $0.577 | $0.577 | $0.544 | 15,200 | |
| $0.558 | +0.008 | +1.5% | $0.580 | $0.580 | $0.550 | 57,600 | |
| $0.550 | -0.013 | -2.3% | $0.560 | $0.565 | $0.540 | 95,500 | |
| $0.563 | -0.014 | -2.4% | $0.564 | $0.564 | $0.550 | 25,900 | |
| $0.577 | -0.038 | -6.2% | $0.588 | $0.588 | $0.557 | 89,900 | |
| $0.615 | 0.000 | 0.0% | $0.600 | $0.615 | $0.580 | 28,300 | |
| $0.615 | -0.001 | -0.2% | $0.591 | $0.619 | $0.590 | 75,800 | |
| $0.616 | +0.011 | +1.8% | $0.584 | $0.616 | $0.580 | 72,100 | |
| $0.605 | -0.003 | -0.5% | $0.593 | $0.607 | $0.588 | 24,100 | |
| $0.608 | -0.018 | -2.9% | $0.622 | $0.622 | $0.584 | 43,300 | |
| $0.626 | +0.021 | +3.5% | $0.600 | $0.628 | $0.590 | 83,400 | |
| $0.605 | -0.035 | -5.5% | $0.630 | $0.630 | $0.600 | 83,800 |
Splits
3 splits since 2023 · NASDAQ:BBLG · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-6 | Consolidation | |
| 1-for-8 | Consolidation | |
| 1-for-30 | Consolidation |
- Ticker
- NASDAQ:BBLG
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 8, 2026
Bone Biologics Expands Trial Sites
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 17 slides
Latest news
Bone Biologics Expands Trial Sites
Sep 8, 2026
Closed $0.56 (-1.4%) on Sep 8, 2026
Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep 3, 2026
Closed $0.558 (+1.5%) on Sep 3, 2026
Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1
Aug 12, 2026
Closed $0.658 (-27.6%) on Aug 12, 2026
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
Jul 23, 2026
Closed $1.08 (-1.8%) on Jul 23, 2026
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Jul 7, 2026
Closed $1.47 (+2.1%) on Jul 7, 2026
Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1
May 19, 2026
Closed $1.26 (+0.8%) on May 19, 2026
Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
Jan 8, 2026
Closed $1.55 (-1.3%) on Jan 8, 2026
Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
Dec 23, 2025
Closed $1.95 (+4.3%) on Dec 23, 2025
Bone Biologics Corp on 6ix
- News releases
- 8 in the last 12 months · 36 in all · newest Sep 8, 2026 · oldest 2020
- Decks
- 5 decks · latest August 2026
Where Bone Biologics Corp is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BBLG · Home listing · This page | NASDAQ | United States | USD |
| BOATS:BBLG | BOATS | United States | USD |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- −$5.18M USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 0.1×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.05
Forecasts
Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.
- Price target
- 12.20 USD · Analysts' mean
- EPS, year to Dec 2026
- -1.18 · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Jeff Frelick | Chief Executive Officer |
Board
| Director | Role |
|---|---|
| Don Hankey | Chairman |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 26, 2026 · After close | −2.4% |
| Q2 2026 | Aug 14, 2026 · After close | +0.8% |
| Q4 2025 | Mar 2, 2026 · After close | +5.7% |
| Q3 2025 | Nov 14, 2025 · After close | +1.7% |
| Q2 2025 | Aug 14, 2025 · After close | −6.4% |
| Q1 2025 | May 12, 2025 · After close | +6.2% |
| Q4 2024 | Feb 26, 2025 · After close | −5.4% |
| Q3 2024 | Nov 14, 2024 · After close | −7.8% |
| Q2 2024 | Aug 9, 2024 · After close | −4.1% |
| Q1 2024 | May 14, 2024 · After close | −1.3% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Feb 20, 2024 · After close | −19.2% |
| Q3 2023 | Nov 14, 2023 · After close | +8.6% |
| Q2 2023 | Aug 14, 2023 · After close | −35.0% |
| Q1 2023 | May 15, 2023 · After close | +4.3% |
| Q4 2022 | Mar 30, 2023 · After close | +5.3% |
| Q3 2022 | Nov 14, 2022 · Before open | −6.0% |
| Q2 2022 | Aug 11, 2022 · After close | +1.6% |
| Q1 2022 | May 13, 2022 · After close | −0.7% |
| Q4 2021 | Mar 15, 2022 · After close | −3.9% |
| Quarter to Sep 30, 2021 | Nov 16, 2021 · After close | −4.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2026) | Investor deck | 17 slides | August 2026 |
| Investor Presentation (December 2024) | Investor deck | 17 slides | December 2024 |
| Investor Presentation (January 2022) | Investor deck | 19 slides | January 2022 |
| Investor Presentation (2019) | Investor deck | 21 slides | 2019 |
| Investor Presentation (July 2018) | Investor deck | 19 slides | Jul 6, 2018 |
Financings
| Raise | Date |
|---|---|
| Private placement of private placement including Series F warrants and Series G warrants Closed: US$3M raised · US$1.42 a share · Warrants at US$1.42 · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Fund clinical trials, maintain and extend patent portfolio, working capital and general corporate purposes | Jul 23, 2026 |
| Public offering of common stock (or common stock equivalents) with Series D and Series E warrants Closed: US$5M raised · US$4 a share · Warrants at US$4 for 60 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Fund clinical trials, maintain and extend patent portfolio, working capital and general corporate purposes | Jun 30, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.07B | 1.07B | 1.07B | |||||||
| Research and development | 1.06M | 2.13M | 6.91M | 1.58M | 82.0K | 340.7K | 1.10M | 104.5K | 1.42M | 10.2M |
| Operating income | -3.23M | -4.22M | -9.43M | -3.67M | -1.10M | -825.0K | -2.45M | -2.79M | -2.63M | -20.4M |
| Depreciation and amortization | 50 | 96 | 96 | 700 | ||||||
| EBITDA | -2.45M | -2.79M | -2.63M | -20.4M | ||||||
| Income before tax | -1.61M | -1.82M | -3.42M | -4.43M | -7.05M | -25.9M | ||||
| Income tax | 1.60K | 1.60K | 1.60K | 1.73K | 1.60K | 2.24K | ||||
| Net income | -3.11M | -4.11M | -8.95M | -1.48M | -1.61M | -1.82M | -3.42M | -4.43M | -7.05M | -25.9M |
| Earnings per share, basic | -2.65 | -28.96 | -34.01 | -31.15 | -0.35 | -0.63 | -0.47 | -0.88 | -1.81 | -0.69 |
| Earnings per share, diluted | -2.65 | -28.96 | -34.01 | -31.15 | -0.35 | -0.63 | -0.47 | -0.88 | -1.81 | -0.69 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 5.33M | 3.33M | 3.03M | 7.54M | 6.68M | 24.1K | 955.4K | 690.3K | 620.4K | |
| Current assets | 5.80M | 3.86M | 3.74M | 8.50M | 30.8K | 1.04M | 795.5K | 700.9K | ||
| Property, plant and equipment | 50 | 146 | 242 | |||||||
| Total assets | 5.80M | 3.86M | 3.74M | 8.50M | 6.68M | 0 | 30.8K | 1.04M | 795.7K | 701.1K |
| Accounts payable | 465.4K | 42.9K | 125.2K | 216.9K | 226.5K | |||||
| Current liabilities | 418.6K | 377.7K | 831.4K | 2.55M | 99.9K | 13.7M | 578.4K | 9.64M | 961.8K | 1.50M |
| Total liabilities | 418.6K | 377.7K | 831.4K | 2.55M | 99.9K | 13.7M | 11.9M | 9.64M | 9.19M | 9.06M |
| Shareholders' equity | 5.38M | 3.48M | 2.91M | 5.95M | 6.58M | -13.7M | -11.9M | -8.60M | -8.40M | -8.36M |
| Shares outstanding | 1.80M | 492.4K | 534.2K | 63.8K | 10.4M | 12.3M | 30.7M | 26.4M | 4.33M | 38.8M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -2.69M | -4.12M | -9.56M | -3.57M | -1.23M | -426.9K | -3.25M | -4.10M | -3.33M | -7.33M |
| Cash from financing | 4.70M | 4.42M | 5.04M | 4.43M | 7.90M | 402.8K | 2.32M | 4.37M | 3.40M | 6.83M |
| Change in cash | 2.01M | 298.6K | -4.51M | 862.9K | 6.68M | -24.1K | -931.2K | 265.1K | 69.9K | -494.7K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13G · Big-stake notice | Nov 16, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 10, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Oct 26, 2026 | Quarterly report | SEC |
| 25-NSE | Oct 13, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2026 | Insider trade | SEC |
| 8-K · Current report | Sep 29, 2026 | Meeting outcome | SEC |
| 8-K · Current report | Sep 16, 2026 | Current report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| DEF 14A · Proxy statement | Aug 28, 2026 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Aug 18, 2026 | Meeting notice | SEC |
| 10-Q · Quarterly report | Aug 14, 2026 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | Jul 27, 2026 | Other filings | SEC |
| 424B3 · Prospectus | Jul 24, 2026 | Offer document | SEC |
| 8-K · Current report | Jul 23, 2026 | Current report | SEC |
| DEFA14A · Additional proxy material | Jul 20, 2026 | Meeting notice | SEC |
| S-3 · Registration statement | Jul 17, 2026 | Offer document | SEC |
| 8-K · Current report | Jul 16, 2026 | Current report | SEC |
| 8-K · Current report | Jul 9, 2026 | Material contract | SEC |
| ARS · Annual report to shareholders | Jul 2, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Jul 2, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Jul 2, 2026 | Meeting notice | SEC |
| 10-Q · Quarterly report | May 14, 2026 | Quarterly report | SEC |
| 8-K · Current report | Mar 13, 2026 | Current report | SEC |
| 424B5 · Prospectus | Mar 13, 2026 | Offer document | SEC |
| 10-K · Annual report | Mar 2, 2026 | Annual report | SEC |
| 4 · Change in ownership | Jan 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 21, 2026 | Insider trade | SEC |
| 8-K · Current report | Jan 8, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Nov 14, 2025 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 7, 2025 | Big-stake notice | SEC |
| S-8 · Registration statement for employee plans | Sep 26, 2025 | Offer document | SEC |
| 8-K · Current report | Sep 4, 2025 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Sep 3, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Aug 29, 2025 | Other filings | SEC |
| S-3/A · Registration statement, amended | Aug 29, 2025 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 3, 2025 | Big-stake notice | SEC |
| UPLOAD · Letter from the SEC | Jul 1, 2025 | Other filings | SEC |
| 8-K · Current report | Jun 30, 2025 | Material contract | SEC |
| 424B4 · Prospectus | Jun 30, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jun 30, 2025 | Other filings | SEC |
| 8-K · Current report | Jun 26, 2025 | Current report | SEC |
| CORRESP · Letter to the SEC | Jun 24, 2025 | Other filings | SEC |
| S-3 · Registration statement | Jun 24, 2025 | Offer document | SEC |
| S-1 · Registration statement | Jun 24, 2025 | Offer document | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 6, 2025 | Current report | SEC |
| 8-K · Current report | May 30, 2025 | Management or board change | SEC |
| 10-Q · Quarterly report | May 12, 2025 | Quarterly report | SEC |
| ARS · Annual report to shareholders | Apr 23, 2025 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 23, 2025 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Apr 11, 2025 | Meeting notice | SEC |
| 8-K · Current report | Apr 11, 2025 | Current report | SEC |
| 8-K · Current report | Apr 1, 2025 | Current report | SEC |
| UPLOAD · Letter from the SEC | Mar 24, 2025 | Other filings | SEC |
| DRS · Draft registration statement | Mar 17, 2025 | Offer document | SEC |
| DRSLTR · Letter to the SEC with a draft | Mar 17, 2025 | Other filings | SEC |
| 10-K · Annual report | Feb 26, 2025 | Annual report | SEC |
| 4 · Change in ownership | Jan 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 21, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 13, 2024 | Current report | SEC |
| 424B5 · Prospectus | Dec 13, 2024 | Offer document | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 14, 2024 | Quarterly report | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 13, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Oct 21, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Oct 18, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Oct 18, 2024 | Insider trade | SEC |
| 8-K · Current report | Oct 4, 2024 | Management or board change | SEC |
| 8-K · Current report | Sep 27, 2024 | Material contract | SEC |
| 424B5 · Prospectus | Sep 27, 2024 | Offer document | SEC |
| 4 · Change in ownership | Sep 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 19, 2024 | Insider trade | SEC |
| 8-K · Current report | Sep 19, 2024 | Meeting outcome | SEC |
| EFFECT · Notice that a registration is effective | Aug 27, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Aug 22, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Aug 21, 2024 | Other filings | SEC |
| S-3 · Registration statement | Aug 12, 2024 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 9, 2024 | Quarterly report | SEC |
| ARS · Annual report to shareholders | Aug 8, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Aug 8, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Aug 8, 2024 | Meeting notice | SEC |
| 8-K · Current report | Aug 2, 2024 | Material contract | SEC |
| SC 13G/A · Big-stake notice, amended | Jun 28, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Jun 20, 2024 | Current report | SEC |
| 10-Q · Quarterly report | May 14, 2024 | Quarterly report | SEC |
| 8-K · Current report | Mar 15, 2024 | Management or board change | SEC |
| SC 13G · Big-stake notice | Mar 14, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Mar 6, 2024 | Material contract | SEC |
| EFFECT · Notice that a registration is effective | Mar 5, 2024 | Other filings | SEC |
| 424B4 · Prospectus | Mar 4, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Mar 1, 2024 | Other filings | SEC |
| 8-K · Current report | Mar 1, 2024 | Current report | SEC |
| CORRESP · Letter to the SEC | Feb 29, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 28, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 27, 2024 | Other filings | SEC |
| S-1/A · Registration statement, amended | Feb 26, 2024 | Offer document | SEC |
| S-1/A · Registration statement, amended | Feb 23, 2024 | Offer document | SEC |
| 10-K · Annual report | Feb 21, 2024 | Annual report | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| UPLOAD · Letter from the SEC | Feb 5, 2024 | Other filings | SEC |
| S-1 · Registration statement | Jan 30, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jan 25, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 22, 2024 | Other filings | SEC |
| 4 · Change in ownership | Jan 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 19, 2024 | Insider trade | SEC |
| S-3/A · Registration statement, amended | Jan 17, 2024 | Offer document | SEC |
| 8-K · Current report | Jan 12, 2024 | Current report | SEC |
| UPLOAD · Letter from the SEC | Jan 11, 2024 | Other filings | SEC |
| 8-K · Current report | Jan 11, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Jan 10, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 10, 2024 | Insider trade | SEC |
| 8-K · Current report | Jan 10, 2024 | Current report | SEC |
| S-3 · Registration statement | Jan 5, 2024 | Offer document | SEC |
| 8-K · Current report | Jan 2, 2024 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 2, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Dec 20, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Dec 18, 2023 | Current report | SEC |
| 8-K · Current report | Dec 13, 2023 | Meeting outcome | SEC |
| D | Nov 29, 2023 | Other filings | SEC |
| SC 13G · Big-stake notice | Nov 27, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Nov 20, 2023 | Material contract | SEC |
| 424B5 · Prospectus | Nov 20, 2023 | Offer document | SEC |
| DEF 14A · Proxy statement | Nov 20, 2023 | Meeting notice | SEC |
| 10-K/A · Annual report, amended | Nov 20, 2023 | Annual report | SEC |
| 10-Q · Quarterly report | Nov 14, 2023 | Quarterly report | SEC |
| PRE 14A · Preliminary proxy statement | Nov 9, 2023 | Meeting notice | SEC |
| 8-K · Current report | Oct 24, 2023 | Current report | SEC |
| 8-K · Current report | Sep 29, 2023 | Current report | SEC |
| 4 · Change in ownership | Sep 20, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 20, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 20, 2023 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Sep 15, 2023 | Offer document | SEC |
| 4 · Change in ownership | Sep 14, 2023 | Insider trade | SEC |
| 8-K · Current report | Sep 12, 2023 | Meeting outcome | SEC |
| 4 · Change in ownership | Sep 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 7, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 14, 2023 | Quarterly report | SEC |
| ARS · Annual report to shareholders | Aug 3, 2023 | Annual report | SEC |
| DEFA14A · Additional proxy material | Aug 3, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Aug 3, 2023 | Meeting notice | SEC |
| 8-K · Current report | Jul 5, 2023 | Current report | SEC |
| SC 13G · Big-stake notice | Jun 26, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Jun 16, 2023 | Material contract | SEC |
| 424B4 · Prospectus | Jun 15, 2023 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jun 15, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 13, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 13, 2023 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jun 13, 2023 | Offer document | SEC |
| S-1/A · Registration statement, amended | Jun 6, 2023 | Offer document | SEC |
| 8-K · Current report | Jun 6, 2023 | Current report | SEC |
| 8-K · Current report | May 19, 2023 | Current report | SEC |
| 10-Q · Quarterly report | May 15, 2023 | Quarterly report | SEC |
| DEF 14C | May 11, 2023 | Meeting notice | SEC |
| UPLOAD · Letter from the SEC | May 8, 2023 | Other filings | SEC |
| S-1 · Registration statement | May 1, 2023 | Offer document | SEC |
| PRE 14C | May 1, 2023 | Meeting notice | SEC |
| 10-K · Annual report | Mar 30, 2023 | Annual report | SEC |
| SC 13D/A · Big-stake notice, amended | Mar 29, 2023 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 29, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 8, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 8, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 8, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 8, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 8, 2023 | Insider trade | SEC |
| SC 13G · Big-stake notice | Feb 14, 2023 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2023 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Jan 4, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Dec 21, 2022 | Management or board change | SEC |
| 8-K · Current report | Nov 21, 2022 | Current report | SEC |
| 10-Q · Quarterly report | Nov 14, 2022 | Quarterly report | SEC |
| 8-K · Current report | Oct 25, 2022 | Current report | SEC |
| 8-K · Current report | Oct 13, 2022 | Current report | SEC |
| SC 13G · Big-stake notice | Oct 11, 2022 | Big-stake notice | SEC |
| 8-K · Current report | Oct 11, 2022 | Material contract | SEC |
| 424B4 · Prospectus | Oct 11, 2022 | Offer document | SEC |
| S-1MEF · Registration of more shares for the same offering | Oct 7, 2022 | Offer document | SEC |
| S-1MEF · Registration of more shares for the same offering | Oct 7, 2022 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Oct 7, 2022 | Other filings | SEC |
| S-1/A · Registration statement, amended | Oct 4, 2022 | Offer document | SEC |
| CORRESP · Letter to the SEC | Oct 4, 2022 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 4, 2022 | Other filings | SEC |
| S-1/A · Registration statement, amended | Oct 4, 2022 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Sep 30, 2022 | Other filings | SEC |
| S-1 · Registration statement | Sep 23, 2022 | Offer document | SEC |
| 8-K · Current report | Aug 23, 2022 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Aug 11, 2022 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | Jul 12, 2022 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 7, 2022 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jul 6, 2022 | Other filings | SEC |
| DEF 14A · Proxy statement | Jul 6, 2022 | Meeting notice | SEC |
This page holds 200 of 487 filings. Open Filings
Cap table
Built by 6ix from Bone Biologics Corp’s releases · as of Oct 26, 2026
- Common shares
- 3,389,057
- Fully diluted
- 3,389,057
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 3,389,057 | Oct 26, 2026 |
Warrants and options
| Lot |
|---|
| Warrants · US$1.42 · expiry not stated |
| Warrants · US$4.00 · expire about Jun 2030 |
Share count over time
| Count | Shares |
|---|---|
| Oct 26, 2026 | 3,389,057 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Gagnon Other companies: Purple Biotech Ltd. (Board Member · Since at least Mar 18, 2026); Opus Genetics, Inc. (Chief Financial Officer · Since at least Sep 2, 2025); Verastem, Inc. (Director · Since at least Aug 28, 2018); Harvard Bioscience, Inc. (Director · Since at least Nov 18, 2013); Clean Harbors, Inc. (EVP CFO and Treasurer · Aug 20, 2012 – Sep 11, 2012 · Past); Biogen Inc. (Vice President, Finance · Nov 3, 2010 – Feb 28, 2012 · Past) | Director · Since at least Jan 8, 2024 |
| Amir F. Heshmatpour Other companies: NeOnc Technologies Holdings, Inc. (CEO, Executive Chairman, and President · Since at least Mar 25, 2025) | Director · Jul 11, 2016 – Jul 14, 2016 · Past |
| Jim Delshad Other companies: NeOnc Technologies Holdings, Inc. (Director · Mar 25, 2025 – Mar 26, 2025 · Past) | Director · Sep 19, 2015 – Jan 1, 2018 · Past |
| Steve La Neve Other companies: Accuray Incorporated (Chief Executive Officer · Since at least Oct 20, 2025) | CEO & President · Aug 17, 2015 – Feb 16, 2018 · Past |
| Bret Hankey | Director · Jul 31, 2017 – Jan 2, 2020 · Past |
| Bruce Stroever | Director · Since at least Oct 26, 2021 |
| Deina H Walsh | Chief Financial Officer · Since at least Jan 3, 2022 |
| Don Hankey | Chairman of the Board, Director · Jul 16, 2018 – Mar 27, 2023 · Past |
| Jeff Frelick | Chief Executive Officer · Since at least Sep 8, 2026 |
| Jeff Frelick | Chief Executive Officer · Since at least Jan 17, 2024 |
All 14 people
| Person | Seat |
|---|---|
| Phillip Terry Meikle II | Director · Since at least Oct 16, 2024 |
| Siddhesh Rajendra Angle | Director · Since at least Oct 15, 2021 |
| William F Coffin | Director · Sep 19, 2015 – Dec 28, 2015 · Past |
| William Jay Treat | Chief Technology Officer · Dec 21, 2015 – Mar 14, 2016 · Past |
Log in to ask 6ix AI your own questions about Bone Biologics Corp.